BR0314911A - Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal - Google Patents

Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Info

Publication number
BR0314911A
BR0314911A BR0314911-0A BR0314911A BR0314911A BR 0314911 A BR0314911 A BR 0314911A BR 0314911 A BR0314911 A BR 0314911A BR 0314911 A BR0314911 A BR 0314911A
Authority
BR
Brazil
Prior art keywords
virus infection
dengue virus
infection inhibitor
monoclonal antibody
hex
Prior art date
Application number
BR0314911-0A
Other languages
English (en)
Inventor
Yasuo Suzuki
Iipal Jwa
Original Assignee
Japan Science & Tech Agency
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science & Tech Agency filed Critical Japan Science & Tech Agency
Publication of BR0314911A publication Critical patent/BR0314911A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024Esters of saccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"INIBIDOR DE INFECçãO POR VìRUS DA DENGUE E COMPOSTO MONOCLONAL". A presente invenção compreende um inibidor de infecção pelo vírus da dengue, na forma de uma droga que efetivamente inibe a infecção do vírus da dengue, que é caracterizada por conter, como o ingrediente ativo, pelo menos uma molécula de carboidrato tendo como um constituinte essencial um oligossacarídeo representado pela seguinte fórmula: Hex¬ 1¬NAc<225>1-3Hex¬ 2¬<225>1-4Hex¬ 1¬<225>1- (I) (onde Hex¬ 1¬ e HeX¬ 2¬ representam uma hexose).
BR0314911-0A 2002-10-22 2003-10-22 Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal BR0314911A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002307232 2002-10-22
PCT/JP2003/013486 WO2004037272A1 (ja) 2002-10-22 2003-10-22 デング熱ウィルス感染阻害剤

Publications (1)

Publication Number Publication Date
BR0314911A true BR0314911A (pt) 2005-09-27

Family

ID=32170933

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314911-0A BR0314911A (pt) 2002-10-22 2003-10-22 Inibidor de infecção pelo vìrus da dengue e anticorpo monoclonal

Country Status (7)

Country Link
US (1) US20060104985A1 (pt)
EP (1) EP1563840A1 (pt)
JP (1) JPWO2004037272A1 (pt)
CN (1) CN1705488A (pt)
BR (1) BR0314911A (pt)
MX (1) MXPA05004379A (pt)
WO (1) WO2004037272A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2349257B1 (en) 2008-06-17 2013-11-27 Universidade Federal de Minas Gerais-UFMG Use of paf receptor for treating infections caused by flaviviridae

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0725689B2 (ja) * 1986-10-07 1995-03-22 中外製薬株式会社 顆粒球コロニ−刺激因子を含有する徐放性製剤
ATE107033T1 (de) * 1987-11-20 1994-06-15 Abbott Lab Nachweis von tumorassozierten anzeigern in biologischen flüssigkeiten.
JPH0687061B2 (ja) * 1988-04-12 1994-11-02 ダイナボット株式会社 糖転移酵素活性の免疫学的測定方法
JPH03115863A (ja) * 1990-09-10 1991-05-16 Dainabotsuto Kk 免疫学的測定法による糖脂質の定量方法
US6197568B1 (en) * 1997-07-29 2001-03-06 The Regents Of The University Of Michigan Method and compositions for isolation, diagnosis and treatment of polyanion-binding microorganisms

Also Published As

Publication number Publication date
CN1705488A (zh) 2005-12-07
JPWO2004037272A1 (ja) 2006-02-23
MXPA05004379A (es) 2005-11-23
EP1563840A1 (en) 2005-08-17
US20060104985A1 (en) 2006-05-18
WO2004037272A1 (ja) 2004-05-06

Similar Documents

Publication Publication Date Title
BR0307356A (pt) Misturas inseticidas sinergìsticas
DE502005010427D1 (de) Physiologisch aktive zusammensetzung gegen diabetes
PE20040972A1 (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
UY29157A1 (es) Composiciones de amitraz
BR0207726A (pt) Sais farmacêuticos
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
BRPI0514536A (pt) uso de oligossacarìdeos não-digerìveis e sacarìdeo de galactose digerìvel, e, composição adequada para o tratamento e/ou prevenção de infecções do trato respiratório e/ou doença de infecção do trato respiratório
GT200200188A (es) Preparacion y uso de derivados de imidazol para el tratamiento de la obesidad
BRPI0207215B8 (pt) Derivados de pirazolopirimidinona tendo ação de inibição de pde7
AR072329A2 (es) Composicion farmaceutica que comprende nateglinida
BRPI0311323B8 (pt) composto inibidor de c-aril glicosídeo sglt2, composição farmacêutica e combinação
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
ES2196527T3 (es) Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
CY1119188T1 (el) Αντιμικροβιακα συντηρητικα για την επιτευξη φαρμακοτεχνικης μορφης πολλαπλης δοσης χρησιμοποιωντας βητα-κυκλοεξτρινες για υγρες μορφες δοσολογιας
BR0212075A (pt) Combinações de substâncias ativas fungicidas
DK1483246T3 (da) 5-Substituerede alkylaminopyrazolderivater som pesticider
BR0312768A (pt) Compostos de 5-ariltetrazol, composições do mesmo e usos dos mesmos
BR0215027A (pt) Derivados de 6-aminomorfinano, processo de preparação para o mesmo e sua aplicação
BR0312921A (pt) Composição compreendendo inibidor de reductase hmg-coa
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0203657A (pt) Formulação sólida
BR0307834A (pt) Misturas inseticidas sinergìsticas
BR9915692A (pt) Monohidrato de bromidrato de eletriptano

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.